This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Events

Flynn Pharma is committed to the delivery of high quality education and supporting the continued development of healthcare professionals – it’s our way of helping you to help your patients.

This educational and promotional event is organised and funded by Flynn Pharma Ltd and Neurim Pharmaceuticals (1991) Ltd (Neurim).

Sleep as a viable target for early intervention in young children with ASD

Thursday 20 February 2025 18:00 - 19:30
Join us for an insightful webinar exploring the critical early intervention period for young children with Autism Spectrum Disorder (ASD), often referred to as the “golden window.” This period may start earlier than traditionally thought, offering a unique opportunity to maximize developmental outcomes.
An account is required to register for this event.
Login
Create Account

Agenda

18:00
The golden window for success may start earlier than you think – benefits of early intervention for children with ASD - Prof. Carmen Schröder
18:20
Early intervention for insomnia – clinical practice aspects and melatonin treatment – Prof. Paul Gringras
18:40
Clinical cases - Prof. Paul Gringras, Prof. Carmen Schröder
19:00
Conclusions and summary
19:15
Q&A

Meet the Speakers

Prof. Carmen M. Schröder, MD.
Prof. Carmen M. Schröder, MD.

Prof. Carmen M. Schröder is a Professor of Child and Adolescent Psychiatry at the Faculty of Medicine in Strasbourg and head of the Department of Child and Adolescent Psychiatry at the University Hospitals in Strasbourg, France. She is also a sleep expert certified by the European Sleep Research Society (ESRS) and holds a PhD in neuroscience with a particular expertise in sleep and chronobiology.

Prof. Paul Gringras, MD.
Prof. Paul Gringras, MD.

Prof. Paul Gringras is a Professor of Sleep Medicine, Kings College London and Consultant in Paediatric Neurodisability and Sleep Medicine, at the Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust. Professor Gringras is currently President of the International Paediatric Sleep Association. His studies include epidemiological work tracking sleep patterns in large numbers of UK children as well as interventional studies and he has written over 100 peer reviewed papers.

What will the webinar cover?

Key learning objectives

  • Explore profound benefits of early intervention, emphasizing how timely and targeted approaches can significantly improve the lives of children with ASD.
  • Explore the clinical practice aspects of identifying and managing insomnia in children with ASD.
  • Provide valuable strategies and practical knowledge to enhance your practice and support the well-being of children with ASD and their families.